Oncology Precision Medicine Market Size, Share & Trends

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Oncology Precision Medicine Market Size Analysis

Global Oncology Precision Medicine Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
  4. Inhibitor drugs
    1. By Value
  5. Monoclonal Antibodies
    1. By Value
  6. Cell & Gene Therapy
    1. By Value
  7. Antiviral & Anti-retroviral drugs
    1. By Value
2. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast cancer
    1. By Value
  3. Lung cancer
    1. By Value
  4. Colorectal cancer
    1. By Value
  5. Prostate cancer
    1. By Value
  6. Cervical cancer
    1. By Value
  7. Kideny Cancer
    1. By Value
  8. Liver Cancer
    1. By Value
  9. Bladder Cancer
    1. By Value
  10. Other applications
    1. By Value
3. By Ecosystem IT Supports
  1. Introduction
    1. Ecosystem IT Supports By Value
  2. Applied sciences
    1. By Value
  3. Precision diagnostics
    1. By Value
  4. Digital health and information technology
    1. By Value
  5. Precision therapeutics
    1. By Value
4. By End Users
  1. Introduction
    1. End Users By Value
  2. Hospitals
    1. By Value
  3. Diagnostics centres
    1. By Value
  4. Research and medical institutes
    1. By Value
  5. Homecare Settings
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
  4. Inhibitor drugs
    1. By Value
  5. Monoclonal Antibodies
    1. By Value
  6. Cell & Gene Therapy
    1. By Value
  7. Antiviral & Anti-retroviral drugs
    1. By Value
2. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast cancer
    1. By Value
  3. Lung cancer
    1. By Value
  4. Colorectal cancer
    1. By Value
  5. Prostate cancer
    1. By Value
  6. Cervical cancer
    1. By Value
  7. Kideny Cancer
    1. By Value
  8. Liver Cancer
    1. By Value
  9. Bladder Cancer
    1. By Value
  10. Other applications
    1. By Value
3. By Ecosystem IT Supports
  1. Introduction
    1. Ecosystem IT Supports By Value
  2. Applied sciences
    1. By Value
  3. Precision diagnostics
    1. By Value
  4. Digital health and information technology
    1. By Value
  5. Precision therapeutics
    1. By Value
4. By End Users
  1. Introduction
    1. End Users By Value
  2. Hospitals
    1. By Value
  3. Diagnostics centres
    1. By Value
  4. Research and medical institutes
    1. By Value
  5. Homecare Settings
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
  4. Inhibitor drugs
    1. By Value
  5. Monoclonal Antibodies
    1. By Value
  6. Cell & Gene Therapy
    1. By Value
  7. Antiviral & Anti-retroviral drugs
    1. By Value
2. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast cancer
    1. By Value
  3. Lung cancer
    1. By Value
  4. Colorectal cancer
    1. By Value
  5. Prostate cancer
    1. By Value
  6. Cervical cancer
    1. By Value
  7. Kideny Cancer
    1. By Value
  8. Liver Cancer
    1. By Value
  9. Bladder Cancer
    1. By Value
  10. Other applications
    1. By Value
3. By Ecosystem IT Supports
  1. Introduction
    1. Ecosystem IT Supports By Value
  2. Applied sciences
    1. By Value
  3. Precision diagnostics
    1. By Value
  4. Digital health and information technology
    1. By Value
  5. Precision therapeutics
    1. By Value
4. By End Users
  1. Introduction
    1. End Users By Value
  2. Hospitals
    1. By Value
  3. Diagnostics centres
    1. By Value
  4. Research and medical institutes
    1. By Value
  5. Homecare Settings
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
  4. Inhibitor drugs
    1. By Value
  5. Monoclonal Antibodies
    1. By Value
  6. Cell & Gene Therapy
    1. By Value
  7. Antiviral & Anti-retroviral drugs
    1. By Value
2. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast cancer
    1. By Value
  3. Lung cancer
    1. By Value
  4. Colorectal cancer
    1. By Value
  5. Prostate cancer
    1. By Value
  6. Cervical cancer
    1. By Value
  7. Kideny Cancer
    1. By Value
  8. Liver Cancer
    1. By Value
  9. Bladder Cancer
    1. By Value
  10. Other applications
    1. By Value
3. By Ecosystem IT Supports
  1. Introduction
    1. Ecosystem IT Supports By Value
  2. Applied sciences
    1. By Value
  3. Precision diagnostics
    1. By Value
  4. Digital health and information technology
    1. By Value
  5. Precision therapeutics
    1. By Value
4. By End Users
  1. Introduction
    1. End Users By Value
  2. Hospitals
    1. By Value
  3. Diagnostics centres
    1. By Value
  4. Research and medical institutes
    1. By Value
  5. Homecare Settings
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
4. Inhibitor drugs
  1. By Value
5. Monoclonal Antibodies
  1. By Value
6. Cell & Gene Therapy
  1. By Value
7. Antiviral & Anti-retroviral drugs
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast cancer
  1. By Value
3. Lung cancer
  1. By Value
4. Colorectal cancer
  1. By Value
5. Prostate cancer
  1. By Value
6. Cervical cancer
  1. By Value
7. Kideny Cancer
  1. By Value
8. Liver Cancer
  1. By Value
9. Bladder Cancer
  1. By Value
10. Other applications
  1. By Value
By Ecosystem IT Supports
1. Introduction
  1. Ecosystem IT Supports By Value
2. Applied sciences
  1. By Value
3. Precision diagnostics
  1. By Value
4. Digital health and information technology
  1. By Value
5. Precision therapeutics
  1. By Value
By End Users
1. Introduction
  1. End Users By Value
2. Hospitals
  1. By Value
3. Diagnostics centres
  1. By Value
4. Research and medical institutes
  1. By Value
5. Homecare Settings
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
  4. Inhibitor drugs
    1. By Value
  5. Monoclonal Antibodies
    1. By Value
  6. Cell & Gene Therapy
    1. By Value
  7. Antiviral & Anti-retroviral drugs
    1. By Value
2. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast cancer
    1. By Value
  3. Lung cancer
    1. By Value
  4. Colorectal cancer
    1. By Value
  5. Prostate cancer
    1. By Value
  6. Cervical cancer
    1. By Value
  7. Kideny Cancer
    1. By Value
  8. Liver Cancer
    1. By Value
  9. Bladder Cancer
    1. By Value
  10. Other applications
    1. By Value
3. By Ecosystem IT Supports
  1. Introduction
    1. Ecosystem IT Supports By Value
  2. Applied sciences
    1. By Value
  3. Precision diagnostics
    1. By Value
  4. Digital health and information technology
    1. By Value
  5. Precision therapeutics
    1. By Value
4. By End Users
  1. Introduction
    1. End Users By Value
  2. Hospitals
    1. By Value
  3. Diagnostics centres
    1. By Value
  4. Research and medical institutes
    1. By Value
  5. Homecare Settings
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Oncology Precision Medicine Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

F Hoffmann-La Roche AG
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Invitae Corporation
Illumina Inc.
Thermo Fisher Scientific Inc.
QIAGEN
Quest Diagnostics
Laboratory Corporation of America Holdings
Novartis AG
AstraZeneca
Bristol-Myers Squibb
Eli Lilly

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment